Conclusions
Resection is the accepted treatment for patients with stage I or II lung cancer; unfortunately, only 25% of patients fall into this category. Following resection, adjuvant therapy has no proven benefit for stage I or II patients. If stage IIIA (N2) disease is suspected on clinical grounds (CT scan, PET scan) and is confirmed histologically (needle biopsy or mediastinoscopy), initial surgery is generally contraindicated. Instead, chemotherapy and radiation are administered to downstage the lesion and potentially render it resectable. If unsuspected, pathologic stage IIIA (N2) disease is discovered following thoracotomy and lobectomy, postoperative irradiation and chemotherapy have proven benefit in terms of prolonging disease-free survival. Stage IIIB disease without N3 involvement may be treated first with chemotherapy and radiation followed by surgery, depending on tumor response. Most surgeons consider N3 disease a sign of inoperability.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832–839.
Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710–1717.
Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440–447.
Ginsberg RJ. Preoperative assessment of the thoracic surgical patient: a surgeon’s viewpoint. In: Pearson FG, Deslauriers J, Hiebert CA, McNeally MF, Ginsberg RJ, Urschel HC (eds) Thoracic Surgery. New York: Churchill Livingstone, 1995:29–36.
O’Donovan PB. The radiologic appearance of lung cancer. Oncology 1997;11:1387–1424.
Steele JD. The solitary pulmonary nodule. J Thorac Cardiovasc Surg 1963;46:21–39.
Kundel HL. Predictive values and threshold detectability of lung tumors. Radiology 1981;139:25–29.
Geddes DM. The natural history of lung cancer: a review based on rates of tumor growth. Br J Dis Chest 1979;73:1–17.
Byrd RB, Carr DT, Miller WE, et al. Radiographic abnormalities in carcinoma of the lung as related to histologic cell type. Thorax 1969;24:573–575.
Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469–476.
Primack SL, Lee KS, Logan PM, et al. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994;193:795–800.
Gross BH, Glazer GM, Orringer MB, et al. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988;166:71–74.
McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319–323.
Maddeus M, Ginsberg RJ. Cancer: diagnosis and staging. In: Pearson FG, Deslauriers J, Hiebert CA, McNeally MF, Ginsberg RJ, Urschel HC (eds) Thoracic Surgery. New York: Churchill Livingstone, 1995:671–690.
Shields TW. Diagnosis and staging of lung cancer. In: Baue AE, Geha AS, Hammond GL, et al. (eds) Glenn’s Thoracic and Cardiovascular Surgery. Stamford, CT: Appleton & Lange, 1996;391–419.
Greco FA, Hainsworth JD. Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. Oncology 1997;11:27–36.
Wahl RL, Quint LE, Greenough RL. Staging of mediastinal non-small cell lung cancer with FDG, PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994;191:371–377.
Minn H, Zasadny KR, Quint LE, et al. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology 1995;196:167–173.
Schiepers C. Role of position emission tomography in the staging of lung cancer. Lung Cancer 1997;17(suppl 1):S29–S35.
Warren WH, Gould VE. Differential diagnosis of small cell neuroendocrine carcinoma of the lung. Chest Surg Clin N Am 1997;7:49–63.
Urschel J. Surgical treatment of peripheral small cell lung cancer. Chest Surg Clin N Am 1997;7:95–103.
Kohman LJ. Is there a place for surgery in central small cell lung cancer? Chest Surg Clin N Am 1997;7:105–112.
Burt M, Heelan RT, Coit D, et al. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer: impact of magnetic resonance imaging. J Thorac Cardiovasc Surg 1994;107:584–589.
Schwartz LH, Ginsberg MS, Burt ME, et al. MRI as an alternative to CT guided biopsy of adrenal masses in patients with lung cancer. Ann Thorac Surg 1998;65:193–197.
Gamsu G. Magnetic resonance imaging in lung cancer. Chest 1986;89:242s–244s.
Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120–129.
Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: five year survival and patterns of recurrence. J Thorac Cardiovasc Surg 1994;107:1087–1094.
Ginsburg RJ. The role of limited resection in the treatment of early stage lung cancer. Lung Cancer 1994;11(suppl 2):S35–S36.
Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037–1049.
Thomas PH, Piantadosi S, Mountain CF. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg 1988;95:883–887.
Shields TW. Presentation, diagnosis and staging of bronchial carcinoma and of the asymptomatic solitary pulmonary nodule. In: Shields TW (ed) General Thoracic Surgery, 4th ed. Philadelphia: Williams & Wilkins, 1994:1122–1154.
Hara N, Ohta M, Tanaka K, et al. Assessment of the role of surgery for stage III bronchogenic carcinoma. J Surg Oncol 1984;25:153–158.
Burt ME, Pomerantz AH, Bains MS, et al. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 1987;67:987–1000.
Raviv G, Klein E, Yellin A, et al. Surgical treatment of solitary adrenal metastases from lung carcinoma. J Surg Oncol 1990;43:123–124.
Reyes L, Parvez Z, Nemoto T, et al. Adrenalectomy for adrenal metastasis from lung carcinoma. J Surg Oncol 1990;44:32–34.
Luketich JD, Martini N, Ginsberg RJ, et al. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg 1995;60:1609–1611.
Wernly JA, DeMeester TR. Preoperative assessment of patients undergoing lung resection for cancer. In: Roth JA, Ruchdeschel JC, Weisenburger TH (eds) Thoracic Oncology. Philadelphia: Saunders, 1989:156–176.
Martinez FJ, Paine R. Medical evaluation of the patient with potentially resectable lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turisi AT (eds) Lung Cancer: Principles and Practice. Philadelphia: Lippincott-Raven, 1995:511–534.
Cohen MC, Eagle KA. Expert opinion regarding indications for coronary angiography before non-coronary cardiac surgery. Am Heart J 1997;134:321–329.
Goldman L. Cardiac risks and complications of non-cardiac surgery. Ann Surg 1983;198:780–791.
Eagle KA. Surgical patients with heart disease: summary of the ACC/AHA guidelines. Am Fam Physician 1997;56:811–818.
Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. J Am Coll Cardiol 1996;27:910–948.
Olsen GN, Bolton JWR, Weiman DS, et al. Stair climbing as an exercise test to predict the postoperative complications of lung resection: two years experience. Chest 1991;99:587–590.
Morice RC, Peters EJ, Ryan MB, et al. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest 1992;101:356–361.
Bechard D, Wetstein L. Assessment of exercise consumption as a preoperative criterion for lung resection. Ann Thorac Surg 1987;44:344–349.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Warren, W.H., James, T.W. (2003). Non-Small Cell Cancer of the Lung. In: Saclarides, T.J., Millikan, K.W., Godellas, C.V. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/0-387-21701-0_19
Download citation
DOI: https://doi.org/10.1007/0-387-21701-0_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95201-7
Online ISBN: 978-0-387-21701-7
eBook Packages: Springer Book Archive